Phase 3 Chemotherapy Induced Peripheral Neuropathy Clinical Trials

3 recruitingPhase 3

What is a Phase 3 trial?

Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.

Showing 1–3 of 3 trials

Recruiting

Phase 3

Capsaicin 179 mg Patch Versus Oral Duloxetine in Patients With Chemotherapy-induced Peripheral Neuropathy

Chemotherapy Induced Peripheral Neuropathy

Institut Cancerologie de l'Ouest274 enrolled11 locationsNCT05840562

Recruiting

Phase 2Phase 3

Ozone Therapy in Chemotherapy-induced Peripheral Neuropathy: RCT (O3NPIQ)

Chemotherapy Induced Peripheral NeuropathyPain SyndromePain, Neuropathic

Bernardino Clavo, MD, PhD42 enrolled2 locationsNCT04299893

Recruiting

Phase 2Phase 3

Methadone to Treat Painful Chemotherapy Induced Peripheral Neuropathy

Chemotherapy Induced Peripheral Neuropathy

University of British Columbia50 enrolled4 locationsNCT05786599